Coalition of investors to challenge Gilead, other drugmakers on policies at annual shareholder meetings

Leading drugmakers could face challenges from a coalition of investors. The proxy proposals center on drug affordability and access.
Click here to view original post

Advertisement — Advertise with Biotech Networks